Related Experiment Video

Updated: Oct 4, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Receptor tyrosine kinase EphA2 is regulated by p53-family proteins and induces apoptosis

M Dohn1, J Jiang, X Chen

  • 1Institute of Molecular Medicine and Genetics, Medical College of Georgia, Augusta, GA 30912, USA.

Oncogene
|October 20, 2001
PubMed

Insights

The p53 tumor suppressor protein regulates EphA2, a gene involved in cancer. Activated EphA2 promotes apoptosis, suggesting a role in tumor suppression and potential therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • The p53 tumor suppressor protein is frequently mutated in human cancers.
  • p53 activation by cellular stress induces target genes, mediating cell cycle arrest and apoptosis.
  • Understanding p53 targets is crucial for cancer management.

Purpose of the Study:

  • To identify novel target genes of the p53 family (p53, p73, p63).
  • To investigate the role of EphA2 in p53-mediated tumor suppression.
  • To explore the therapeutic potential of EphA2 in cancer treatment.

Main Methods:

  • Identification of EphA2 as a p53 family target gene.
  • Analysis of EphA2 transcript and protein expression.
  • Characterization of a p53 response element in the EphA2 promoter.
  • Generation of stable cell lines with inducible EphA2 expression.
  • Assessment of apoptosis induction by EphA2.

Main Results:

  • EphA2 is a direct transcriptional target of p53, p73, and p63.
  • EphA2 expression and protein levels increase upon DNA damage and p53 activation.
  • A functional p53 response element was identified in the EphA2 promoter.
  • EphA2 expression induces apoptosis, suggesting a tumor suppressive role.
  • Ephrin-A1, the EphA2 ligand, is also regulated by p53.

Conclusions:

  • EphA2 is a novel target gene of the p53 family, playing a role in p53-mediated tumor suppression.
  • EphA2 induction enhances apoptosis, potentially by disrupting anti-apoptotic signaling pathways.
  • Targeting the EphA2 pathway may offer new therapeutic strategies for cancer treatment.

More Related Videos

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

Development and Application of Rapamycin-regulated Tyrosine Phosphatases06:56

Development and Application of Rapamycin-regulated Tyrosine Phosphatases

Published on: September 6, 2024

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...